Can you shed some light on this
Rising GLP-1 demand challenges employer health plans With the steady increase in obesity rates, GLP-1 drugs seem like a convenient solution
The authors note that they determined depression based on a claims data algorithm
In: Rasmussen KM, Yaktine AL, editors
A BMI of 30 to 34.9, or 27.5 to 32.4 for people of Asian, Chinese, Middle Eastern, Black African or African-Caribbean origin, who meet other criteria to be treated by a specialist weight management service
Taking it before, during, or after a meal will have a negligible, if any, impact on its bioavailability and subsequent effectiveness in a research setting